RNA m6A甲基化修饰在脂肪细胞胰岛素抵抗中的作用机制

叶棣文, 张炳杨, 张丹彤, 马万山, 逯素梅

PDF(4642 KB)
PDF(4642 KB)
重庆医科大学学报 ›› 2024, Vol. 49 ›› Issue (02) : 132-140. DOI: 10.13406/j.cnki.cyxb.003432
基础研究 DOI:10.13406/j.cnki.cyxb.003432

RNA m6A甲基化修饰在脂肪细胞胰岛素抵抗中的作用机制

作者信息 +

The role of RNA m6A methylation in insulin resistance in adipocytes

Author information +
History +

摘要

目的 探讨RNA m6A甲基化修饰在脂肪细胞胰岛素抵抗中的作用及机制。 方法 收集2型糖尿病患者术中赘余皮下脂肪组织,以非2型糖尿病患者同样组织为对照,检测组间RNA m6A水平。高脂饮食诱导C57BL/6J小鼠构建胰岛素抵抗(insulin resistance,IR)模型(HFD组,n=5,60%高脂饲料喂养16周),对照组10%低脂饲料喂养16周(CD组,n=5)。模型构建成功后,取附睾周围脂肪组织行表观转录组学m6A甲基化修饰芯片检测,并借助MeRIP-qPCR实验、RT-qPCR以及RNA结合蛋白免疫沉淀测定(RNA Binding Protein Immunoprecipitation Assay,RIP)实验验证胰岛素信号转导相关基因变化;进一步观察METTL3小分子抑制剂STM2457对高脂饮食诱导下小鼠胰岛素信号转导基因的影响。 结果 2型糖尿病患者和小鼠IR模型脂肪组织中总体m6A修饰水平均升高(患者200 ng RNA t=-8.375,P<0.001;患者100 ng RNA t=-3.722,P=0.006;患者50 ng RNA t=-4.937;P=0.001;小鼠100 ng RNA t=-3.590,P=0.023;小鼠50 ng RNA t=-2.760,P=0.025)。表观转录组学检测证实IR的脂肪组织中1 175个基因发生高m6A修饰,55个基因发生低m6A修饰,同时有182个基因呈现高m6A修饰且低表达,包括AKT2、INSR、PIK3R1、ACACA、SREBF1等5个胰岛素信号转导关键基因,其中AKT2、INSR、ACACA、SREBF1等4个基因被确证并证实其与METTL3存在直接结合,其m6A修饰水平受METTL3正向调控。STM2457作用下,胰岛素敏感性提高,且AKT2、INSR、ACACA、SREBF1转录水平上调,提示IR表型改善明显。 结论 高脂饮食通过METTL3诱导脂肪细胞胰岛素信号转导基因AKT2、INSR、ACACA、SREBF1发生m6A高甲基化修饰,诱导其低表达,阻滞胰岛素信号转导,进而参与诱发IR。

Abstract

Objective To explore the role of RNA m6A methylation in insulin resistance in adipocytes. Methods We collected redundant subcutaneous adipose tissue samples from patients with type 2 diabetes and patients without type 2 diabetes to measure the RNA m6A modification level. A insulin resistance(IR) model was established by feeding C57BL/6J mice with a 60% high-fat diet for 16 weeks(n=5),while the control group was fed with a 10% low-fat diet for 16 weeks(n=5). After successful modeling,the adipose tissue around the epididymis was taken to detect m6A methylation using epitranscriptomic microarrays. The changes in insulin signaling-related genes were determined by MeRIP-qPCR assay,RT-qPCR,and RIP assay. The effects of the small-molecule inhibitor STM2457 targeting methyltransferase like 3(METTL3) on insulin signaling-related genes in mice feeding a high-fat diet were investigated. Results The overall m6A modification levels were significantly increased in the adipose tissue of patients with type 2 diabetes and IR mice(patients 200 ng RNA,t=-8.375,P<0.001;patients 100 ng RNA,t=-3.722,P=0.006;patients 50 ng RNA,t=-4.937,P=0.001;mice 100 ng RNA,t=-3.590,P=0.023;mice 50 ng RNA,t=-2.760,P=0.025). The epitranscriptomic assay detected high m6A methylation levels in 1 175 genes and low m6A methylation levels in 55 genes;182 genes showed significantly high m6A modification and low expression,including five key insulin signaling-related genes(AKT2INSRPIK3R1ACACA,and SREBF1). Direct binding between AKT2INSRACACA,and SREBF1 and METTL3 was validated,and their m6A modification levels were positively regulated by METTL3. STM2457 significantly increased insulin sensitivity,and significantly upregulated the transcriptional levels of AKT2INSRACACA,and SREBF1,suggesting a significant improvement in IR phenotype. Conclusion High-fat diet induces IR through METTL3,which mediates m6A hypermethylation of AKT2INSRACACA,and SREBF1 to downregulate their expression and block insulin signaling in adipocytes.

关键词

高脂饮食 / 胰岛素抵抗 / RNA m6A甲基化修饰 / 胰岛素信号转导通路

Key words

high-fat diet / insulin resistance / RNA m6A methylation / insulin signaling pathway

中图分类号

R34

引用本文

导出引用
叶棣文 , 张炳杨 , 张丹彤 , . RNA m6A甲基化修饰在脂肪细胞胰岛素抵抗中的作用机制. 重庆医科大学学报. 2024, 49(02): 132-140 https://doi.org/10.13406/j.cnki.cyxb.003432
Ye Diwen, Zhang Bingyang, Zhang Dantong, et al. The role of RNA m6A methylation in insulin resistance in adipocytes[J]. Journal of Chongqing Medical University. 2024, 49(02): 132-140 https://doi.org/10.13406/j.cnki.cyxb.003432

参考文献

1
Shi QY Nong KL Vandvik PO,et al. Benefits and harms of drug treatment for type 2 diabetes:systematic review and network meta-analysis of randomised controlled trials[J]. BMJ2023381:e074068.
2
Jonas DE Vander Schaaf EB Riley S,et al. Screening for prediabetes and type 2 diabetes in children and adolescents:evidence report and systematic review for the US preventive services task force[J]. JAMA2022328(10):968-979.
3
Saltiel AR. Insulin signaling in health and disease[J]. J Clin Invest2021131(1):e142241.
4
Galicia-Garcia U Benito-Vicente A Jebari S,et al. Pathophysiology of type 2 diabetes mellitus[J]. Int J Mol Sci202021(17):6275.
5
Yang Q Vijayakumar A Kahn BB. Metabolites as regulators of insulin sensitivity and metabolism[J]. Nat Rev Mol Cell Biol201819(10):654-672.
6
Prudente S Morini E Trischitta V. Insulin signaling regulating genes:effect on T2DM and cardiovascular risk[J]. Nat Rev Endocrinol20095(12):682-693.
7
Sharma M Dey CS. AKT ISOFORMS-AS160-GLUT4:the defining axis of insulin resistance[J]. Rev Endocr Metab Disord202122(4):973-986.
8
Zaccara S Ries RJ Jaffrey SR. Reading,writing and erasing mRNA methylation[J]. Nat Rev Mol Cell Biol201920(10):608-624.
9
Horiuchi K Kawamura T Hamakubo T. Wilms' tumor 1-associating protein complex regulates alternative splicing and polyadenylation at potential G-quadruplex-forming splice site sequences[J]. J Biol Chem2021297(5):101248.
10
Zhou B Liu CZ Xu LY,et al. N6-methyladenosine reader protein YT521-B homology domain-containing 2 suppresses liver steatosis by regulation of mRNA stability of lipogenic genes[J]. Hepatology202173(1):91-103.
11
Chen YS Ouyang XP Yu XH,et al. N6-adenosine methylation (m6A) RNA modification:an emerging role in cardiovascular diseases[J]. J Cardiovasc Transl Res202114(5):857-872.
12
Ben-Haim MS Pinto Y Moshitch-Moshkovitz S,et al. Dynamic regulation of N6,2'-O-dimethyladenosine (m6Am) in obesity[J]. Nat Commun202112(1):7185.
13
Sun ML Zhang XN. Epigenetic regulation of N6-methyladenosine modifications in obesity[J]. J Diabetes Investig202112(8):1306-1315.
14
Tao XX Du RL Guo SM,et al. PGE2-EP3 axis promotes brown adipose tissue formation through stabilization of WTAP RNA methyltransferase[J]. EMBO J202241(16):e110439.
15
中国超重/肥胖医学营养治疗指南(2021)[J]. 中国医学前沿杂志(电子版),202113(11):1-55.
Chinese Guidelines for Medical Nutrition Therapy of Overweight/Obesity2021)[J]. Chinese Journal of the Frontiers of Medical Science(Electronic Version),202113(11):1-55.
16
Xu ZJ Lv BB Qin Y,et al. Emerging roles and mechanism of m6A methylation in cardiometabolic diseases[J]. Cells202211(7):1101.
17
Zhu LY Fu J Xiao X,et al. Faecal microbiota transplantation-mediated jejunal microbiota changes halt high-fat diet-induced obesity in mice via retarding intestinal fat absorption[J]. Microb Biotechnol202215(1):337-352.
18
Chen JQ Lai K Yong X,et al. Silencing METTL3 stabilizes atherosclerotic plaques by regulating the phenotypic transformation of vascular smooth muscle cells via the miR-375-3p/PDK1 axis[J]. Cardiovasc Drugs Ther202337(3):471-486.
19
Yu ZH Zheng XL Wang CH,et al. The traditional Chinese medicine Hua Tuo Zai Zao Wan alleviates atherosclerosis by deactivation of inflammatory macrophages[J]. Evid Based Complement Alternat Med20222022:2200662.
20
Xie RX Yan SJ Zhou XL,et al. Activation of METTL3 promotes white adipose tissue beiging and combats obesity[J]. Diabetes202372(8):1083-1094.
21
Bataglia L Simões ZLP Nunes FMF. Transcriptional expression of m6A and m5C RNA methyltransferase genes in the brain and fat body of honey bee adult workers[J]. Front Cell Dev Biol202210:921503.
22
Wang XX Zhu LN Chen JQ,et al. mRNA m⁶A methylation downregulates adipogenesis in porcine adipocytes[J]. Biochem Biophys Res Commun2015459(2):201-207.
23
Zhou N Qi HL Liu JJ,et al. Deubiquitinase OTUD3 regulates metabolism homeostasis in response to nutritional stresses[J]. Cell Metab202234(7):1023-1041.
24
Li YQ Zhang DT Gao YN,et al. METTL3 exacerbates insulin resistance in hepatocytes by regulating m6A modification of cytochrome P450 2B6[J]. Nutr Metab202320(1):1-14.
25
Wang ZQ Zhang XH Yu YM,et al. Artemisia scoparia extract attenuates non-alcoholic fatty liver disease in diet-induced obesity mice by enhancing hepatic insulin and AMPK signaling independently of FGF21 pathway[J]. Metabolism201362(9):1239-1249.
26
Chen C Nott TJ Jin J,et al. Deciphering arginine methylation:Tudor tells the tale[J]. Nat Rev Mol Cell Biol201112(10):629-642.
27
AlAbdulKader AM Tuwairqi K Rao G. Obesity and cardiovascular risk in the Arab Gulf states[J]. Curr Cardiovasc Risk Rep202014(7):1-9.
28
Li YL Li L Liu YH,et al. Identification of metabolism-related proteins as biomarkers of insulin resistance and potential mechanisms of m6A modification[J]. Nutrients202315(8):1839.
29
Wu RF Chen YS Liu YH,et al. m6A methylation promotes white-to-beige fat transition by facilitating Hif1a translation[J]. EMBO Rep202122(11):e52348.
30
Wang XX Wu RF Liu YH,et al. m6A mRNA methylation controls autophagy and adipogenesis by targeting Atg5 and Atg7 [J]. Autophagy202016(7):1221-1235.
31
Xie W Ma LL Xu YQ,et al. METTL3 inhibits hepatic insulin sensitivity via N6-methyladenosine modification of Fasn mRNA and promoting fatty acid metabolism[J]. Biochem Biophys Res Commun2019518(1):120-126.
32
Dang YQ Xu JJ Yang Y,et al. Ling-Gui-Zhu-Gan decoction alleviates hepatic steatosis through SOCS2 modification by N6-methyladenosine[J]. Biomedecine Pharmacother2020127:109976.

基金

山东省自然科学基金资助项目(ZR2023MH031)
山东第一医科大学青年科学基金培育资助计划项目(202201-083)

评论

PDF(4642 KB)

Accesses

Citation

Detail

段落导航
相关文章

/